BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14261022)

  • 1. VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE.
    SHEPARD CC
    Am J Epidemiol; 1965 Mar; 81():150-63. PubMed ID: 14261022
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF VACCINATION BY ATYPICAL MYCOBACTERIA IN EXPERIMENTAL MURINE LEPROSY.
    GUPTA SK; MATHUR IS
    Indian J Med Res; 1964 May; 52():435-40. PubMed ID: 14175599
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination of mice against Mycobacterium leprae infection.
    Singh NB; Lowe AC; Rees RJ; Colston MJ
    Infect Immun; 1989 Feb; 57(2):653-5. PubMed ID: 2643581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against leprosy].
    Grosset J; Lecoeur H
    Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467
    [No Abstract]   [Full Text] [Related]  

  • 5. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.
    Bretscher PA
    Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae.
    Ngamying M; Sawanpanyalert P; Butraporn R; Nikasri J; Cho SN; Levy L; Brennan PJ
    Infect Immun; 2003 Mar; 71(3):1596-8. PubMed ID: 12595485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.
    Gelber RH; Brennan PJ; Hunter SW; Munn MW; Monson JM; Murray LP; Siu P; Tsang M; Engleman EG; Mohagheghpour N
    Infect Immun; 1990 Mar; 58(3):711-8. PubMed ID: 2407654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination in leprosy--observations and interpretations.
    Convit J; Ulrich M; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):62-5. PubMed ID: 6988347
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The BCG has antigenic similarity with Hansen's bacillus upon which the Mycobacterium marianum cannot prevail].
    MONTESTRUC E
    Bull Soc Pathol Exot Filiales; 1955; 48(5):629-31. PubMed ID: 13329711
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present perspectives in leprosy.
    BROWNE SG
    Scott Med J; 1962 Oct; 7():446-53. PubMed ID: 14016080
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of mice against M. leprae infection.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):222-6. PubMed ID: 776860
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards new leprosy and tuberculosis vaccines.
    Kaufmann S
    Microbiol Sci; 1987 Nov; 4(11):324-8. PubMed ID: 3155274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.